PEXVODI Trademark

Trademark Overview

On Tuesday, February 2, 2016, a trademark application was filed for PEXVODI with the United States Patent and Trademark Office. The USPTO has given the PEXVODI trademark a serial number of 86895209. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, March 30, 2020. This trademark is owned by Bristol-Myers Squibb Company. The PEXVODI trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for human use for the treatment and prevention of obesity, diabetes, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection; pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants and pharmaceutical antibodies
pexvodi

General Information

Serial Number86895209
Word MarkPEXVODI
Filing DateTuesday, February 2, 2016
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, March 30, 2020
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 3, 2017

Trademark Statements

Goods and ServicesPharmaceutical preparations for human use for the treatment and prevention of obesity, diabetes, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection; pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants and pharmaceutical antibodies

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSaturday, February 6, 2016
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameBristol-Myers Squibb Company
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 10016
Party NameBristol-Myers Squibb Company
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10154

Trademark Events

Event DateEvent Description
Monday, March 30, 2020ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, March 30, 2020ABANDONMENT - NO USE STATEMENT FILED
Saturday, September 14, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, September 13, 2019EXTENSION 5 GRANTED
Tuesday, August 20, 2019EXTENSION 5 FILED
Tuesday, August 20, 2019TEAS EXTENSION RECEIVED
Friday, February 15, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, February 13, 2019EXTENSION 4 GRANTED
Wednesday, February 13, 2019EXTENSION 4 FILED
Wednesday, February 13, 2019TEAS EXTENSION RECEIVED
Monday, October 8, 2018APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, October 8, 2018TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, August 22, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, August 20, 2018EXTENSION 3 GRANTED
Monday, August 20, 2018EXTENSION 3 FILED
Monday, August 20, 2018TEAS EXTENSION RECEIVED
Wednesday, February 28, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, February 26, 2018EXTENSION 2 GRANTED
Monday, February 26, 2018EXTENSION 2 FILED
Monday, February 26, 2018TEAS EXTENSION RECEIVED
Thursday, November 9, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, November 8, 2017EXTENSION 1 GRANTED
Monday, August 28, 2017EXTENSION 1 FILED
Tuesday, November 7, 2017CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, October 26, 2017NOTICE OF REVIVAL - E-MAILED
Thursday, October 26, 2017EXTENSION RECEIVED WITH TEAS PETITION
Thursday, October 26, 2017PETITION TO REVIVE-GRANTED
Thursday, October 26, 2017TEAS PETITION TO REVIVE RECEIVED
Monday, October 2, 2017ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, October 2, 2017ABANDONMENT - NO USE STATEMENT FILED
Tuesday, February 28, 2017NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, January 3, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 3, 2017PUBLISHED FOR OPPOSITION
Wednesday, December 14, 2016NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, November 25, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, November 23, 2016TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, November 23, 2016CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, November 23, 2016TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, May 24, 2016NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, May 24, 2016NON-FINAL ACTION E-MAILED
Tuesday, May 24, 2016NON-FINAL ACTION WRITTEN
Tuesday, May 17, 2016ASSIGNED TO EXAMINER
Saturday, February 6, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, February 5, 2016NEW APPLICATION ENTERED IN TRAM

Related Keywords

pexvodi diseases pharmaceutical human anti preparations disorders organ solid auto immune